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Morphogenesis of the heart requires development of the endocardial cushion tissue that gives rise to the membranous septa and valves.
Here we show that Meltrin h/ADAM19, a novel metalloprotease-disintegrin, participates in the development of the endocardial cushion.
Mice lacking Meltrin h exhibit ventricular septal defect (VSD) and immature valves, and most of the animals die soon after birth. During
development of the endocardial cushion, epithelial–mesenchymal transformation (EMT) of endocardial epithelial cells generates most of the
cushion mesenchymes that constitute the main components of the septa and valves. Meltrin h is expressed in both the epithelia and the
mesenchymes of the endocardial cushion. In the absence of Meltrin h, the cushion is small or thin in the septum-forming region and show
poor remodeling of cardiac jelly components; both of these characteristics suggest impaired growth and differentiation of the endocardial
cushion. When embryonic fibroblasts are cultured sparsely, Meltrin h-lacking cells exhibit aberrant ectodomain shedding of type I
Neuregulin, one of the ErbB ligands expressed in endocardial cells. These results suggest the necessity of proteolytic regulation of ErbB
ligands by Meltrin h for proper heart development.
D 2003 Elsevier Inc. All rights reserved.Keywords: Metalloprotease; Disintegrin; ErbB; Neuregulin; Knockout mouse; VSD; Endocardial cushionIntroduction
Meltrin h (ADAM19) is a member of the ADAM
family of membrane proteins that contain metalloprotease
and disintegrin domains (Inoue et al., 1998; Kurisaki et
al., 1998; Yagami-Hiromasa et al., 1995). ADAMs play
important roles in fertilization (Blobel et al., 1992; Cho et
al., 1998; Nishimura et al., 2001) and various aspects of
morphogenesis (Fambrough et al.,1996; Gilpin et al.,0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2003.10.021
Abbreviations: ADAM, a disintegrin and metalloprotease; DAPI, 6-
diamidino-2-phenylindole; EMT, epithelial–mesenchymal transformation;
GFP, green fluorescent protein; HA, hemagglutinin; EGFR, epidermal
growth factor receptor; HB-EGF, heparin-binding EGF; LTBP-1, latent
TGF-h binding protein-1; PMA, phorbol 12-myristate 13-acetate; TNF-a,
tumor necrosis factor-a; TACE, TNF-a converting enzyme; TGF-a,
transforming growth factor-a; VSD, ventricular septal defect; DMEM,
Dulbecco’s modified Eagle’s medium.
* Corresponding author. Fax: +81-75-751-4642.
E-mail address: asehara@frontier.kyoto-u.ac.jp (A. Sehara-Fujisawa).1998; Huang et al., 2003; Kurisaki et al., 2003; Peschon
et al., 1998; Rooke et al., 1996; Yagami-Hiromasa et al.,
1995) and are implicated in certain pathogeneses (Asakura
et al., 2002; Van Eerdewegh et al., 2002). Genetic and
biochemical studies have revealed that some ADAMs
participate in the ectodomain shedding (proteolysis of
membrane proteins at the extracellular juxta-membrane
region) of various membrane-anchored proteins, growth
factors, intercellular signaling molecules, and adhesion
molecules (Black and White, 1998; Seals and Court-
neidge, 2003; Werb and Yan, 1998). Kuzbanian (AD-
AM10), for example, is involved in neurogenesis and
other morphogeneses through proteolytic regulation of
Notch signaling (Pan and Rubin, 1997; Qi et al., 1999).
Tumor Necrosis Factor-a (TNF-a) converting enzyme
(TACE) (ADAM17) converts various membrane proteins
such as TNF-a and Transforming Growth Factor (TGF)-a
from their membrane-bound to soluble forms (Black et al.,
1997; Moss et al., 1997; Peschon et al., 1998). We
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main shedding of type I Neuregulin-1 h1, one of the
membrane-anchored ErbB ligands that are expressed in
the nervous system and heart (Shirakabe et al., 2001).
Because Meltrin h is expressed in the neurons of cranio-
facial and dorsal root ganglia, it is conceivable that this
membrane-bound protease modulates the action of Neu-
regulin that is expressed in these neurons. Although our
results indicated that Meltrin h protease indeed has a role
in ectodomain shedding, they prompted numerous ques-
tions regarding the biological roles of Meltrin h and its
substrate specificity in vivo.
In the present study, we set out to determine whether Mel-
trin h plays important roles in development or morphogen-
esis. Generation of meltrin b gene knockout (Meltrin h/)
mice revealed that Meltrin h is involved in development of
the heart. Similarities in the mRNA expression patterns of
Neuregulin and Meltrin h in the endocardial cushion and a
defect of Meltrin h/ cells in phorbol 12-myristate 13-
acetate (PMA)-induced ectodomain shedding when they
were cultured at low cell density suggested roles of Meltrin
h in modulation of the ectodomain shedding of ErbB
ligands during endocardial development. At the same time,
our results revealed that Meltrin h is not the only protease
that is responsible for the ectodomain shedding of Neu-
regulin. We discuss the possible function of Meltrin h in
light of the phenotypes of Meltrin h/ mice, and weFig. 1. Disruption of the murine meltrin h gene and the proportion of surviving off
vector designed to delete meltrin h exons 10, 11, and 12, encoding a zinc-bindin
boxes, corresponding to Meltrin h cDNA nucleotides 802 through 1461). In hom
line) results in a frame-shift mutation at the beginning of the next exon (exon 13:
(neo) driven by the PGK promoter and the diphtheria toxin-A (DT-A) gene we
embryonic stem cells (E14.1) containing the proper recombination of the meltrin b
recombination site (purple box). (B) Southern blot analysis of HindIII-digested ge
probe reveals the 7-kb wild-type and 4.1-kb mutant fragments. (C) RT-PCR analysi
the deleted region (red arrows). Deletion of the three meltrin h exons in Meltrin h
Meltrin h+/ matings.compare its roles with those of ErbB receptors and their
ligands.Materials and methods
Generation of Meltrin b/ (Meltrin bdMP/dMP) mice and
Southern blot analysis
Mouse genomic BAC clones (Research Genetics, Inc.)
were screened with mouse Meltrin h cDNA (Kurohara et
al., 2000), and a 120-kb BAC clone encompassing exons
coding for cDNA (nucleotides 802 through 1461) was
isolated. The active site of the Meltrin h metalloprotease
was in exon 11. To obtain embryonic stem cells in which the
region through exons 10 to 12 was deleted, we used the 8.0-
kb NheI–NheI and 1.6-kb PstI–NdeI fragments as the 5V-
and 3V-homologous regions of these exons, respectively. A
neomycin resistance gene driven by the PGK promoter was
placed between the 5V- and 3V-homologous regions to allow
positive selection. These fragments were cloned into a
vector containing the diphtheria toxin A (DT-A) gene,
which allows negative selection. This vector was electro-
porated into embryonic stem cells (E14.1), and targeted
clones were used to generate chimeric animals. Germline
transmission of the disrupted allele was examined by PCR
and Southern blotting by using a probe for a sequence in thespring from Meltrin h+/ matings. (A) Schematic depiction of the targeting
g motif and neighboring sequences within the metalloprotease domain (red
ologous recombinants, removal of the region containing these exons (gray
green) and leads to a truncated gene product. A neomycin resistance gene
re introduced for positive and negative selections, respectively, to isolate
gene. Recombination was detected with a probe to the 3V region outside the
nomic DNA isolated from tails of wild-type and mutant neonatal mice. The
s of mRNA from E12.5 embryos by using primers in exons 8 and 14 outside
/ mice generates a 0.3-kb band. (D) The surviving ratios of offspring from
Fig. 2. Defects in heart development of neonatal and adult Meltrin h / 
mice. A and B show hematoxylin and eosin (HE)-stained sections of the
hearts of postnatal day (P)1 wild-type (A) and Meltrin h / (B) mice. The
arrow in B indicates a ventricular septal defect. Hearts of wild-type (C and
E) and Meltrin h / (D, F, and G) mice at 9 months of age. LA, left
atrium; LV, left ventricle; RA, right atrium; RV, right ventricle. Scale bars, 5
mm. Cross sections of the hearts of wild-type (E) and Meltrin h /  (F)
mice show the markedly enlarged right ventricle of the Meltrin h /  heart.
Scale bars, 1 mm.
Fig. 3. Defects in valve development of neonatal and adult Meltrin h / 
mice. A through G show hematoxylin and eosin (HE)-stained sections of
the hearts of postnatal day (P)1 wild-type (A, C, and E), Meltrin h / (B,
D, and F), and adult (9 month of age) Meltrin h / (G) mice. Arrowheads
in A and B indicate pulmonary valve. Arrowheads and arrows in C and D
denote aortic valve and left atrioventricular (AV) (mitral) valve,
respectively. Arrows in E and F show right AV (tricuspid) valves. G shows
immature pulmonary valves of an adult Meltrin h /  mouse. LV, left
ventricle; RV, right ventricle. Scale bars, 200 Am.
K. Kurohara et al. / Developmental Biology 267 (2004) 14–28163V region outside the recombination site. Genotypes of mice
were analyzed with DNA isolated from tails of neonates or
at the age of 3 weeks. Genotypes of embryos were carried
out with DNA isolated from amnion or pieces of tissues. All
the analyses shown in this study were performed with mice
of mixed background of SV129 and C57BL6/J at F2-F4.
The same phenotypes were confirmed in mice backcrossed
with C57BL6/J at N8.
Reverse transcription (RT)-PCR analysis
mRNAwas extracted from the spinal cord and dorsal root
ganglia of E12.0 embryos by using the Micro-Fast-Track
2.0 kit (Invitrogen), and 2 ng of mRNA was subjected to
one-step RT-PCR amplification. Reverse transcription was
carried out with Super Script II reverse transcriptase (Life
Technologies, Inc.). Primers outside the deleted region were
used to amplify Meltrin h cDNA over the disrupted exon
region (sense primer [beginning at nucleotide 777 on exon
8], 5V-GGAGATTGCCAACTATGTTGAT-3V; antisenseprimer [beginning at nucleotide 1477 on exon 14] 5V-
TTCCAGGAGCCACCAGCTTGCACT-3V).
In situ hybridization
In situ hybridization was performed essentially as de-
scribed previously with digoxigenin-labeled antisense and
sense riboprobes prepared by in vitro transcription accord-
ing to the manufacturer’s protocol (Roche Molecular Bio-
chemicals) (Kurisaki et al., 1998). The antisense probe for
Meltrin h was described previously (Kurisaki et al., 1998).
Complementary DNAs for mouse Neuregulin mRNA
(regions spanning from amino acid 1 to 223 and from 224
K. Kurohara et al. / Developmental Biology 267 (2004) 14–28 17to 644) and ErbB3 (from 4 to 2165, region covering
amino acids 1–721, and from 2572 to 4021, covering the
amino acid 858-termination codon) were cloned into pBlue-
script. These plasmids were used as templates to make sense
and anti-sense probes.
Histology and immunohistochemistry
For hematoxylin and eosin staining, samples fixed with
4% paraformaldehyde in PBS() were embedded in
paraffin blocks, from which 4-Am serial sections were
cut. Histological studies were performed by standard
methods. For immunostaining, fresh frozen samples were
embedded in OCT compound, and serial sections (8–12
Am) were cut with a cryostat. The cryosections were fixed
in ice-cold fresh 4% paraformaldehyde in PBS() for 10
min, then washed in PBS(), blocked with 2% skim
milk, and stained by using antibodies against the follow-
ing proteins: Meltrin h (an antibody against a C-terminal
oligopeptide, 1:200 dilution) (Shirakabe et al., 2001),
latent TGF-h binding protein-1 (LTBP-1) (Ab-39, donated
by Dr. Kohei Miyazono, 1:800 dilution), Fibronectin
(3E3, Sigma, 1:800 dilution), Integrin a4 (9C10, BD
Pharmingen, 1:200 dilution), VE-cadherin (11D4.1, BD
Pharmingen, 1:200 dilution), and PECAM-1 (MEC13.3,
BD Pharmingen, 1:200 dilution). Fluorescent-labelled sec-
ondary antibodies (1:400 dilution) were obtained from
Amersham and Molecular Probes. Photographs were taken
on a Zeiss fluorescent microscope with MetaMorph soft-
ware (Universal Imaging Corporation). Whole-mount im-
munohistochemistry was performed as described (EricksonFig. 4. Defects in the nervous system and skeletal muscle of perinatal Meltrin h / 
Meltrin h /  (B) P1 mice. (C and D) Whole-mount immunohistochemistry using
type (C) and Meltrin h / (D) mice. Fasciculation of the preganglionic neuron tet al., 1997) by using anti-NF160 antibodies (NN18,
Sigma, 1:400 dilution).
Cell culture and Western blotting
Fibroblasts from mouse embryos were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% FBS. Cells were seeded at 6  105
(low density) or 1.6  106 (high density) per 10-cm dish,
and on the next day, they were transfected with the HA-
NRG h1 plasmid (a plasmid to express Neuregulin h1),
tagged with the hemagglutinin (HA) epitope at its N
terminus together with pEGFP-C1 (Green Fluorescent
Protein [GFP], Clontech) by using LipofectAMINE2000
(Invitrogen) essentially as described previously (Shirakabe
et al., 2001). The Meltrin h-expression plasmid was co-
transfected when it was described (Shirakabe et al., 2001).
The cells were harvested after 24 h. For PMA stimulation,
cells were washed with DMEM and treated with 4 ml
DMEM with or without 100 nM PMA for 30 min before
harvesting cells. To know whether metalloproteases are
responsible for the production of soluble HA-tagged
Neuregulin h1, 10 AM TAPI (TNF-a protease inhibitor,
Sigma) was included in the culture medium when it was
described. Immunoblotting of the conditioned media was
performed as described previously (Shirakabe et al.,
2001). The data were normalized relative to the expression
of GFP, which was detected with rabbit polyclonal anti-
GFP antibody (MBL, Nagoya, Japan). Quantities of HA-
Neuregulin h1 in the cell and culture medium were
determined by laser densitometry of immunoblots bymice. A and B show sagittal sections of the diaphragm of wild-type (A) and
anti-neurofilament-160 antibody of the right adrenal glands of E18.5 wild-
hrough the adrenal medulla is impaired in Meltrin h /  mice.
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Quant software.Fig. 5. Meltrin h, Neuregulin, and ErbB3 mRNAs are co-expressed in the
endocardial cushion but in different manners. In situ hybridization of mouse
embryonic sections at E11.5 showing the heart. Anti-sense probes were
used to detect Meltrin h mRNA (A, C), Neuregulin mRNA (E, G), and
ErbB3 mRNA (I, K), and sense probes for Meltrin h (B, D), Neuregulin (F,
H), and ErbB3 (J, L). C, D, G, H, K, and L are the enlarged view of A, B, E,
F, I, and J, respectively. Arrowheads indicate corresponding sites. Stars
denote ventricles. Scale bars, 100 Am. Note that strong expression of
Neuregulin and ErbB3 is found in the epithelial and mesenchymal cell
populations, respectively, whereas Meltrin h is expressed in both cell types.Results
Generation of mice lacking Meltrin b protease
To determine the roles of the meltrin b gene in vivo, we
generated mice lacking the gene. We introduced a construct
designed to delete the active site of the metalloprotease
domain of Meltrin h (exon 11; Fig. 1A), thereby generating
Meltrin hyMP/yMP mice (yMP, deletion of metalloprotease;
described as Meltrin h/ in this study). Southern blotting
and RT-PCR confirmed that the appropriate exons (exons
10, 11, and 12) were disrupted in the Meltrin h/ mice and
that these mice were functionally null mutants for Meltrin h
protease (Figs. 1B, C). The construct for gene targeting was
designed to introduce termination codons at exon 13 by
generating frame-shift mutations, so that the mutant mice
could express only an N-terminal truncated polypeptide
instead of full-length Meltrin h. We recently identified
cDNAs that encode an alternatively spliced isoform of
Meltrin h that lacks the metalloprotease and disintegrin
domains; we call this isoform Meltrin h-mini. This gene
product may be a regulator of Meltrin h and other ADAMs
(Kurisaki et al., 2002). It is theoretically possible that
Meltrin h/ mice still express Meltrin h-mini-like isoforms
that lack the metalloprotease active site. However, an
antibody against an oligopeptide at the C terminus of
Meltrin h, which can also recognize Meltrin h-mini
expressed in cultured cells, did not detect such isoforms in
the hearts of Meltrin h/ mice (data shown below) by
immunohistochemical methods and Western blotting. The
results indicate that expression of Meltrin h-mini is much
lower than that of the protease-domain containing Meltrin h.
Meltrin b/ mice show defects in heart formation and
other developmental defects
Although Meltrin h/ mice were born alive, most died
within a week (Fig. 1D). Histological analyses revealed that
all 12 of the hearts examined from newborn Meltrin h/
mice had a defect of the membranous part of the ventricular
septum (Figs. 2A, B). The pulmonary and aortic valves of
the Meltrin h/ heart were morphologically immature
(Figs. 3A through D); this was evident in 10 out of 12
Meltrin h/ mice. The defects in aortic valves were milder
than those of the pulmonary valves. In some Meltrin h/
mice, formation of the atrioventricular (AV) valves was also
affected (Figs. 3C through F). Compared with the severely
impaired right AV (tricupsid) valve, found in 10 out of 12
mice, the left AV(mitral) valve was either mildly affected (3
out of 12 mice) or apparently normal (Fig. 2B). The aorta
arose over the septal defect (overriding aorta; data not
shown). Of the 16 surviving adult Meltrin h/ mice
K. Kurohara et al. / Developmental Biology 267 (2004) 14–28 19examined, 10 showed enlargement of the heart, particularly
of the right ventricle (Figs. 2C through F). Ventricular septal
defects (VSDs) were evident in three of the four adult
Meltrin h/ mice examined (data not shown). In some of
adult Meltrin h/ mice (two of six), there was a small hole
between the aorta and pulmonary artery (A–P window; data
not shown), and the pulmonary valve was also immature
(Fig. 3G). These defects most likely arose because of
impaired endocardial cushion development. The Meltrin
h/ mice also showed other developmental defects. Some
of their skeletal muscles (exemplified by the diaphragm)Fig. 6. Expression of Meltrin h protein in the embryonic heart. A through D sh
antibodies of transverse sections of E11.5 wild-type (A and C) and Meltrin h /  (
cushions are shown. Nuclei were stained with DAPI (4,6-diamidino-2-phenylin
mesenchymes. Meltrin h is strongly expressed in the endocardial epithelial cell lay
wild-type (A and C) mice, but no expression is found in Meltrin h /  (B and D) m
anti-Meltrin h (red) and anti-PECAM-1 (green) antibodies of transverse sections o
AV cushions are shown. F and I are merged views of signals of Meltrin h (E and H
with DAPI. The cushion tissues, including their epithelial and mesenchymal cell
PECAM-1-positive (yellow arrowheads) or PECAM-1-negative (yellow arrow). Sig
cushion epithelia because they are not reproducible. Scale bars, 20 Am.were thinner than those of wild-type littermates (Figs. 4A,
B). In fact, some of the Meltrin h/ mice developed much
thinner diaphragm muscles than the one pictured here. The
decreased myogenesis was not caused by a reduction in the
number of myofibers but by a difference in their thickness.
Although the effect of the absence of Meltrin h on the
nervous system, which strongly expresses Meltrin h (Kur-
isaki et al., 1998), requires more detailed analysis, we did
note that penetration of thick preganglionic neuron bundles
into the adrenal medulla was impaired in Meltrin h/ mice
(Figs. 4C, D).ow immunostaining with anti-Meltrin h (red) and anti-integrin a4 (green)
B and D) hearts. The outflow tract (A and B) and atrioventricular (C and D)
dole). Regions surrounded by dashed lines indicate endocardial cushion
er (ep) and mesenchymal cushion cells delaminating from this layer (cu) in
ice. ot: surface of the outflow tract. E through J show immunostaining with
f E11.5 wild-type (E, F, and G) and Meltrin h / (H, I, and J) hearts. The
) and PECAM-1. G and J are merged views of F and I, with nuclei stained
s, are surrounded by dashed lines. In G, Meltrin h-positive cells are either
nals in H are considered to be background signals in the cardiac muscle and
mental Biology 267 (2004) 14–28Overlapping expression of Meltrin b and Neuregulin in the
endocardial cushion during development
Meltrin h mRNA is expressed mainly in the heart and
nervous system during development. In the heart, Meltrin h
mRNA is strongly expressed in both the endocardial epi-
thelial cells and cushion mesenchymes, most of which are
generated from the endocardial epithelia through epithelial–
mesenchymal transformation (EMT) (Figs. 5A and C).
Weak Meltrin h mRNA expression was also found in heart
muscle. Because Meltrin h has an activity of the ectodomain
shedding of type I Neuregulin h1, we examined whether
transcripts of the meltrin b gene colocalize with those of the
neuregulin gene in the heart. Partial overlaps between areas
of expression of these transcripts were found in the endo-
cardial cushion tissue at embryonic day (E) 11.5; in contrast
to the wider distribution of Meltrin h mRNA, the neuregulin
gene was activated only at the tips of the outermost
epithelial cell layers and was weak in the mesenchymes
after EMT (Figs. 5E, G). Transcription of the meltrin b gene
decreased after E13.5 in the heart (data not shown). The
tissues affected in Meltrin h/ mice were similar to those
affected in ErbB3-deficient mice. ErbB3 plays essential
roles in the development of the cardiac cushion, survival
of glial cells in the nervous system, and development of the
adrenal medulla and is strongly expressed in skeletal muscle
K. Kurohara et al. / Develop20Fig. 7. Impaired development of endocardial cushion in Meltrin h / mice. A thr
(green) antibodies of transverse sections of E12.5 wild-type (A) and Meltrin h /
The atrioventricular cushions at the septum-forming regions are shown. Every t
maximum sizes of the cushion tissues. Cushion tissues, including epithelial and m
thickness of the cushion between wild-type and Meltrin h /  hearts is indicated by
wild-type heart at E13.5. Diagram shows the location of the atrioventricular endoca
(ms), both of which ultimately fuse with each other to close the interventricular f(Britsch et al., 1998; Erickson et al., 1997; Riethmacher et
al, 1997). Both the erbB3 and meltrin b genes were
expressed in the endocardial cushion, although expression
pattern of Meltrin h and ErbB3 mRNA appeared different
from each other. The signals of ErbB3 mRNA were much
stronger in the cushion mesenchymes than in the epithelial
layer (Figs. 5I, K).
Immunostaining confirmed the expression of Meltrin h
protein in the endocardial cushion of the outflow tract and in
the AV cushion (Figs. 6 and 7). When the cushion was
stained with antibodies against Meltrin h (red) and Integrin
a4 (green), a marker of the cushion mesenchymes (Yang et
al., 1995), Meltrin h was found in Integrin a4-positive
mesenchymes (the yellow cells in the cushion mesenchymes
in Figs. 6A, C) and in Integrin a4-negative endocardial
epithelial cells and cells undergoing EMT (stained pink in
the epithelia in Figs. 6A, C). This was further confirmed by
co-staining with anti-PECAM-1 antibody. PECAM-1, a
marker of endocardial epithelial cells, marks the margins
of the cushion and muscle tissues. Fig. 6E shows weak
expression of Meltrin h in PECAM-1-positive cells and its
strong expression in PECAM-1-negative mesenchymes in
the wild-type heart. Such PECAM-1 and Meltrin h-double
positive cells in E11.5 hearts appear to represent cell
populations undergoing EMT. Majority of Meltrin h-posi-
tive cells were PE-CAM-negative mesenchymes at E12.5ough D show immunostaining with anti-Meltrin h (red) and anti-PECAM-1
(B) hearts and those of E13.5 wild-type (C) and Meltrin h / (D) hearts.
hird section was examined to select regions containing cushion tissues of
esenchymal cells, are roughly surrounded by dashed lines. The difference in
the yellow arrow in C and D. Note decreased expression of Meltrin h in the
rdial cushions (cu, red) and the muscular part of the interventricular septum
oramen (fo). Scale bars, 20 Am.
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(Fig. 7C). Meltrin h/ hearts did not stain with anti-Meltrin
h antibody (Figs. 6B, D, J and Figs. 7B and D), which
shows that Meltrin h/ mice essentially do not express
Meltrin h protein, including Meltrin h-mini, and confirms
the specificity of the anti-Meltrin h antibody. The endocar-
dial cushion mesenchymes start to appear at E10.5 (data not
shown), and the ventricular septum in mice starts to be
formed between E11.5 and E12.5. Therefore, Meltrin h is
expressed widely throughout the endocardial cushion in an
early stage of its development, and is required for its
development.
Impaired development of endocardial cushion tissue in
Meltrin b/ mice
To detect initial signs of the differences in cushion
development between wild-type and Meltrin h/ hearts,Fig. 8. Impaired cushion distribution of Meltrin h / mice at E14.5. A through F
wild-type (A, C, and E) and Meltrin h / (B, D, and F) mice. Every third sect
(surrounded by yellow lines). A and B indicate the cushion at the aortic valve-f
Arrowheads in D and E and arrows in E and F show left and right AV valves, resp
the left atrioventricular valve of the wild-type heart (E). LV, left ventricle; RV, riwe analyzed their serial sections through E11.5 to E14.5.
Fig. 8 shows representative AV cushion tissues at E14.5.
The regions surrounded by yellow lines in Figs. 8A/B, C/D,
and E/F are representative cushion tissues that give rise to
the aortic valve, the membranous part of the interventricular
septum, and the AV valves, respectively. In the Meltrin h/
heart, there is much less cushion tissue distributed in the
septum-forming region than in the wild-type heart (Fig. 8D).
In contrast, the cushion tissues in the aortic valve- and AV
valve-forming regions of Meltrin h/ heart were similar in
size or slightly larger than those of the wild-type heart (Figs.
8A/B and E/F). Thus, the distribution of cushion tissue
before septum and valve formation is affected in the Meltrin
h/ heart. During the development of valves and septa, the
cushion tissues are remodeled into membranous compo-
nents. This tissue remodeling is initiated in the left AV
valves at E14.5 in the wild-type heart (indicated with an
arrowhead in Fig. 8E). The Meltrin h/ heart exhibitsshow hematoxylin and eosin (HE)-stained sections of the hearts of E14.5
ion was examined to select regions with cushion tissues of maximum size
orming region. C and D shows the cushion at the septum-forming region.
ectively. Note that morphogenesis of the membranous tissue is detectable in
ght ventricle. Scale bars, 200 Am.
K. Kurohara et al. / Developmental Biology 267 (2004) 14–2822slight retardation of cushion tissue remodeling at this stage
(Figs. 8D and F), and this retardation is more evident at
E17.5 (data not shown).Fig. 9. Defective fibrillogenesis of cardiac jelly components at the septum-fo
interventricular foramen is on the right. The ventricular septum-forming region of w
characterized by examining the expression of Fibronectin (A, B, E, F, I, and J, gree
G, and F and H, respectively, together with DAPI. A, C, and I are different section
same Meltrin h / mouse to avoid possible selections of specific samples. Cushio
LTBP-1 in the Meltrin h /  cushion. cu, endocardial cushion; ms, muscular part oFig. 7 compares the junction of the AV cushion and
muscular septum in Meltrin h/ mice with those of wild-
type littermates. The smaller or thinner cushion of therming region. In A through J, the interventricular muscular septum or
ild-type (A, C, E, G, I) and Meltrin h / (B, D, F, H, J) mice at E11.5 was
n) and LTBP-1 (C, D, G, H, I, and J, red). I and J are merged view of E and
s of the same wild-type mouse, and B, D, and J are different sections of the
n tissue is surrounded by dashed lines. Note a fine mesh of Fibronectin and
f the interventricular septum; fo, interventricular foramen. Scale bars, 20 Am.
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E12.5 and E13.5. The total numbers of Integrin a4-positive
cells in serial sections of the Meltrin h/ mice were 60–
80% of those of wild-type littermates at E11.5 (data not
shown), suggesting the defects in production of cushion
mesenchymes in the Meltrin h/ mice. Furthermore, we
investigated the expression of cardiac jelly components as
molecular markers of the cushion development at E11.5–
12.5. Both LTBP-1 (Nakajima et al., 1997) and Fibronectin
(Icardo et al., 1992) are components of the cardiac jelly
fibrils that play important roles in cushion development. In
the wild-type AV cushion, the level of synthesis of these
extracellular matrix proteins are not very high compared to
that in the outflow tract, but their deposition was localized
near the margins of the cushion tissues (Figs. 9A and C).
Their cushion mesenchymes developed thick fibrils includ-
ing Fibronectin and LTBP-1 (Figs. 9E, G, and I). In contrast,
in the AV cushion of the Meltrin h/ mice, fine meshes ofFig. 10. Aberrant ectodomain shedding of Neuregulin h1 in Meltrin h / embr
Meltrin h. Bands for the proprotein-domain-containing inactive forms and the p
arrowhead and an arrow, respectively. (B) Representative Western blots of Neureg
or densely cultured embryonic fibroblasts prepared from wild-type (+/+) and Melt
express Neuregulin-h1 tagged with the HA epitope at its N terminus (HA-NRG-h
were cultured in fresh medium with or without PMA for 30 min, and the soluble fo
expressed in the cells were collected for immunoblotting with an antibody agai
independent experiments. Vertical axis shows the relative intensity of the HA signa
PMA in the Meltrin h / cells cultured at low cell density. An asterisk indicates athin fibrils were spread throughout the mesenchymes of the
cushion despite high level of expression of LTBP-1 and
Fibronectin (Figs. 9B, D, F, H, and J). Such differences in
fibrillogenesis and distribution of cardiac jelly components
at the septum-forming region were found in several pairs of
wild-type and Meltrin h/ littermates. Fine meshes of
LTBP-1 and Fibronectin were similarly found in immature
cushion mesenchymes at E10.5 of both the wild-type and
Meltrin h/ mice (data not shown). These results suggest
retardation of cushion development or impaired differenti-
ation of cushion mesenchymes in the Meltrin h/ heart.
Aberrant ectodomain shedding of Neuregulin in Meltrin
b/ cells
Because Meltrin h has a proteolytic activity that partic-
ipates in the ectodomain shedding of type I Neuregulin h1
in established cell lines such as L929 fibroblasts, weyonic fibroblasts cultured at low cell density. (A) Immunoblot analysis of
roprotein-domain-removed active forms of Meltrin h are indicated by an
ulin h1 released in the culture medium and that in the cell lysate in sparsely
rin h /  ( / ) mice. Cultured cells were transfected with the plasmid to
1) (Shirakabe et al., 2001). After the cells had been cultured for 24 h, they
rm of HA-NRG-h1 released into the culture medium and the uncleaved form
nst HA tag. (C) Densitometric analysis of immunoblots obtained in four
l to the GFP signal. Note that shedding of Neuregulin was not enhanced by
statistically significant difference ( P < 0.05) between experimental groups.
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mice. The production of soluble Neuregulin h1 carrying an
HA tag at its N terminus from the membrane-anchored
precursor form (Shirakabe et al., 2001) was monitored in
embryonic fibroblasts prepared from wild-type and Meltrin
h/ mice. PMA-induced shedding activity of Neuregulins
has been reported previously (Loeb et al., 1998). When
wild-type cells were cultured at low cell densities, ectodo-
main shedding in them was stimulated by PMA treatment.
In contrast, Meltrin h/ cells did not show PMA-enhancedFig. 11. PMA-induced ectodomain shedding of Neuregulin h1 impaired in
Meltrin h / embryonic fibroblasts was rescued by expression of Meltrin
h. In A and B, wild-type (1, 2) and Meltrin h /  (3, 4) cells cultured at low
cell density were transfected with the plasmid to express HA-Neuregulin h1
together with expression plasmids for Meltrin h (2, 4) or a vector itself (1,
3). After the cells were cultured for 24 h, they were treated with or without
PMA for 30 min, and the soluble form of HA-NRG-h1 released into the
culture medium and the uncleaved form expressed in the cells were
collected for immunoblotting with an antibody against Meltrin h (A) and
HA tag (B). Representative Western blot is shown. (C) Western blot
indicating decreased ectodomain sheddings as a result of treatment of the
wild-type and Meltrin h /  ( / ) cells with 10 AM TAPI either with or
without PMA.shedding, although their constitutive shedding activity was
retained (Fig. 10). Meltrin h/ cells showed an increase in
constitutive shedding activity in this assay. When consid-
ered together with the expression of Neuregulin and Meltrin
h in the endocardial cushion, this result suggests that the
sparse endocardial mesenchymes use Meltrin h to cleave
Neuregulin or related ErbB ligands in response to some
stimuli that are mimicked by PMA treatment in vitro. PMA-
enhanced shedding in Meltrin h/ cells was rescued by
expression of Meltrin h together with Neuregulin h1,
whereas constitutive shedding was neither enhanced nor
suppressed. On the other hand, overexpression of Meltrin h
in wild-type cells enhanced both PMA-dependent and
-independent activities. As a result, PMA-dependent and
-independent shedding activities in the existence of exoge-
nous Meltrin h were more or less the same in wild-type and
Meltrin h/ cells (Fig. 11). Treatment of the cells with
TAPI (TNF-a protease inhibitor), a hydroxamic acid-based
metalloprotease inhibitor, significantly reduced constitutive
shedding activity, suggesting that metalloproteases such as
ADAM and matrix metalloproteases are responsible for
production of soluble Neuregulin h1 (Fig. 11C). In contrast
to the findings from low-density cultures, Meltrin h/ cells
cultured at densities high enough to permit efficient cell–
cell contacts recovered the PMA-induced shedding activity
that was absent at low cell density. This result indicates that
other proteases can work as PMA-inducible ‘‘sheddases’’ of
Neuregulin in this condition, and that the regulatory mech-
anisms of these alternative enzymes appear to be different
from that of Meltrin h protease.Discussion
We generated the meltrin b/adam19 gene knockout
(Meltrin h/) mice to investigate the biological roles of
Meltrin h in vivo. We found that Meltrin h participates in
the development of the heart, nervous system, and skeletal
muscle. In the heart, the occurrence of VSD and immature
valve formation in the Meltrin h/ mice indicates the
essential roles of Meltrin h in the development of the
endocardial cushion.
On the basis of the strong expression of Meltrin h in the
endocardial cushion of the normal heart at E11.5 and E12.5,
we explored initial signs of abnormality in Meltrin h/
hearts. The proper growth and/or distribution of the cushion
tissue that is required for closure of the interventricular
septum was affected in Meltrin h/ hearts at E14.5. In
wild-type mice, interventricular septum closes with the
cushion tissue at approximately E12.5. Impaired develop-
ment of the AV cushion, and especially of the septum-
forming region, was already evident at that stage in the
Meltrin h/ heart. On the other hand, morphogenesis of the
AV valves and their tissue remodeling from the cushion
mesenchymes to the membranous valves start after E12.5
and is evident by E14.5 in wild-type mice. Slight retardation
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h/ heart at E14.5. Thus, one of the initial signs of
abnormality in the Meltrin h/ heart is a defect of proper
cushion growth before morphogenesis.
The AV cushion develops dramatically between E10.5
and E12.5. Although the precise mechanisms of prolifera-
tion and distribution of cushion cells in the heart remain
unclear, recent studies have shown that EMT of endocardial
cells, which occurs in both the atrioventricular and conus
cushions, gives rise to the membranous septa and valves of
the heart (Kisanuki et al., 2001). Therefore, it is plausible
that the lack of Meltrin h in the endocardial cushion affects
EMT of the epithelial cells or migration of the cushion
mesenchymes after their production by EMT. Alternatively,
defective differentiation of the cushion mesenchymes may
affect their further growth or distribution to the septum-
forming region in the Meltrin h/ heart. To examine such
possibilities, we investigated the expression of LTBP-1 and
Fibronectin, both of which are components of cardiac jelly
synthesized in the cushion and play roles in its development.
We noted differences in the fibrillogenesis of cardiac jelly
components between Meltrin h/ mice and their wild-type
littermates. Cardiac jelly is important for storing and local-
izing TGF-h family proteins as latent forms. It is conceiv-
able that generating thick fibrils of cardiac jelly at the
marginal zones of the cushion, denoting remodeling of the
fiber matrices, is required for the efficient release of TGF-h
activity that ultimately modulate EMT (Boyer et al., 1999;
Brown et al., 1999). Despite their strong expression in
cushion tissue, Fibronectin and LTBP-1 were found only
as thin fibrils in the AV cushion of Meltrin h/ mice at
E11.5, suggesting poor differentiation of the cushion mes-
enchymes because of a lack of Meltrin h. Thus, another sign
of abnormality in the Meltrin h/ heart is defective
differentiation of cushion mesenchymes at E11.5 before
their enlargement and morphogenesis. Similar roles of
ADAM proteins in remodeling of extracellular matrix pro-
teins were reported previously by Alfandari et al. (2001).
They showed that ectopic expression of Xenopus ADAM13
can remodel Fibronectin matrices in cultured cells (Alfan-
dari et al., 2001).
In light of these analyses of the Meltrin h/ mice, we
consider that Meltrin h is one of the modulators of the
intercellular signalings that are required for development of
the endocardial cushion. We previously reported that Mel-
trin h mediates the ectodomain shedding of Neuregulin
(Shirakabe et al., 2001). Neuregulin (Neurregulin-1: also
known as heregulin, acetylcholine receptor inducing activ-
ity, glial growth factor, and neu differentiation factor)
promotes the proliferation and differentiation of various cell
types. The biological effects of Neuregulin are mediated by
tyrosine kinase receptors belonging to the ErbB family,
which consists of epidermal growth factor receptor
(EGFR/ErbB1), ErbB2, ErbB3, and ErbB4 (reviewed by
Buonanno and Fischbach, 2001; Falls 2003). Targeted
disruption of the genes for Neuregulins and ErbB receptorshas revealed that Neuregulin and ErbB participate in the
development of the nervous system and heart (Britsch et al.,
1998; Erickson et al., 1997; Gassmann et al., 1995; Golding
et al., 2000; Meyer and Birchmeier, 1995; Ozcelik et al.,
2002; Riethmacher et al., 1997). Meltrin h is a membrane-
bound protease and participates in the cleavage of mem-
brane-anchored substrate proteins expressed in the same
cell. We indeed detected Neuregulin mRNA in the endocar-
dial epithelial cells and Meltrin h mRNA in the endocardial
epithelia and mesenchymes in adjacent paraffin sections. In
contrast to Meltrin h mRNA, prominent expression of
Meltrin h protein was found mainly in the cushion mesen-
chymes. Because endocardial cushion mesenchymes essen-
tially originate from endocardial epithelial cells in the AV
and conus cushion (Kisanuki et al., 2001), Neuregulin that is
produced before EMT can be a substrate of Meltrin h, both
in the epithelia and in the mesenchymes after EMT. Expres-
sion of Meltrin h was prominent through E11.5 to E12.5,
and decreased after E13.5. This temporary activation of
Meltrin h likely leads to transient generation of soluble
ligands in the endocardial cushion. On the basis of defects in
migration of ErbB3-positive cells in the sympathetic ner-
vous system of Neuregulin/ mice and defective develop-
ment of the cardiac cushion, the nervous system, and the
adrenal medulla in ErbB3/ mice (Britsch et al., 1998;
Erickson et al., 1997; Riethmacher et al., 1997), we also
examined expression of ErbB3 in the heart. ErbB3-positive
cells were found in the cushion mesenchymes. Although
Neuregulin, Meltrin h, and ErbB3 mRNA showed slightly
different expression patterns in the endocardial cushion,
these data suggest an intimate relationship among the three
genes.
To our surprise, embryonic fibroblasts of Meltrin h/
mice cleaved Neuregulin h1 efficiently, whereas PMA-
induced stimulation of ectodomain shedding of Neuregulin
h1 was not evident in these cells. This effect was observed
only when the cells were cultured sparsely. In this culture
condition, cells are loosely attached to each other similar to
endocardial cushion mesenchymes at E11.5. We interpret
these data as evidence that Meltrin h is involved in PMA-
dependent ectodomain shedding of Neuregulin or related
ErbB ligands in the cushion mesenchymes, and this activity
is lost in Meltrin h/ cells. Co-transfection with Meltrin h-
expression plasmids restored PMA-inducible cleavage of
HA-Neuregulin h1 but did not enhance or suppress the
constitutive activity of Meltrin h/ cells. In contrast,
overexpression of Meltrin h in wild-type cells stimulated
both constitutive and PMA-inducible proteolysis of the
ligand, which was similar to effects of Meltrin h in L929
fibroblasts (Shirakabe et al., 2001). The rescued PMA-
induced shedding with Meltrin h in Meltrin h/ cells
suggests that at least part of the PMA-induced shedding
activity in sparsely cultured cells requires Meltrin h. Over-
expression of Meltrin h may perturb regulation of its
protease action in transient transfection experiments al-
though we cannot exclude possibilities that Meltrin h plays
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-independent sheddings. On the other hand, proteolytic
pathways independent from Meltrin h seems to be up-
regulated in Meltrin h/ cells. The constitutive activities
in Meltrin h/ cells were sensitive to TAPI, suggesting that
metalloproteases such as matrix metalloproteases or other
ADAMs such as Kuzbanian (ADAM10) are responsible for
these activities. In either case, the perturbed cleavage of
Neuregulin h1 suggests alterations in the regulatory path-
ways of the production and/or incorporation of ErbB ligands
in Meltrin h/ cells.
When we cultured the cells at densities high enough to
permit efficient cell–cell contacts, the PMA-induced shed-
ding activity that was absent at low cell density was present
in Meltrin h/ cells, indicating that other proteases are
involved in the ectodomain shedding of Neuregulin at high
cell density. One candidate is TACE, as it is involved in the
PMA-induced cleavage of various ErbB ligands, namely,
TGF-a, heparin-binding EGF (HB-EGF), and Neuregulin
(Merlos-Suarez et al., 2001; Montero et al., 2000; Peschon
et al., 1998; Sunnarborg et al., 2002). Jackson et al. (2003)
reported that TACE/ mice show defective cardiac valvu-
logenesis and suggested the involvement of TACE in the
ectodomain shedding of the ErbB ligands, HB-EGF and
Betacellulin. Another candidate is Meltrin a (ADAM12).
Meltrin a/ embryonic fibroblasts showed impaired PMA-
induced ectodomain shedding of endogenous HB-EGF
(Kurisaki et al., 2003). Furthermore, preliminary experi-
ments indicate that Meltrin a can also cleave Neuregulin h1
(Azuma R., personal communication). In the future, the
proteases responsible will be determined by the knockdown
of these candidates in Meltrin h/ cells or by the gener-
ation of double knockout mice. Thus, involvement of
Meltrin h in the ectodomain shedding of Neuregulin h1
or other ErbB ligands was supported by co-expression of
Meltrin h and Neuregulin in the cushion tissues and by
aberrant ectodomain shedding of Neuregulin h1 in Meltrin
h/ cells although it is difficult currently to conclude that
Neuregulin is the sole substrate of the Meltrin h protease
and Meltrin h is a sole protease responsible for the ectodo-
main shedding of Neuregulin.
Meltrin h/ mice show defective growth of the AV
cushion at the septum-forming region, and exhibit insuffi-
cient remodeling of cardiac jelly components, suggesting
regulatory roles for Meltrin h in the growth and differenti-
ation of cushion mesenchymes. The roles of Meltrin h in
cushion development may well be relevant to previous
reports that endocardial cushion development requires
EGFR (Chen et al., 2000), ErbB2 (Camenisch et al., 2002)
and ErbB3 (Camenisch et al., 2002; Erickson et al., 1997),
and their ligands Neuregulin (Camenisch et al., 2002) and
HB-EGF (Iwamoto et al., 2003; Jackson et al., 2003).
Camenisch et al. reported that Neuregulins and their
ErbB2/ErbB3 receptors are involved in EMT of endocardial
cells. Meltrin h also participates in the fasciculation of axon
bundles or pathfinding of preganglionic neurons in theadrenal medulla. The proper development of the nervous
system, especially axon pathfinding and survival of glial
cells, also involves ErbB2, ErbB3, ErbB4, and Neuregulin
(Britsch et al., 1998; Erickson et al., 1997; Gassmann et al.,
1995; Golding et al., 2000; Meyer and Birchmeier, 1995).
Taking these results together, it is plausible that Meltrin h
modulates the ectodomain shedding of ErbB ligands such as
Neuregulin, and that the generated ligands stimulate hetero-
dimeric ErbB receptors, such as EGFR/ErbB3 or ErbB2/
ErbB3, in the endocardial cushion cells.
Because numerous membrane-anchored ErbB and EGFR
ligands are structurally similar to Neuregulin, including
Neuregulin-2 (Carraway et al., 1997), HB-EGF, and TGF-
a, Meltrin h may also participate in the ectodomain
shedding of these ligands. Furthermore, TNF-related acti-
vation-induced cytokine (TRANCE) was reported to be
another candidate substrate (Chesneau et al., 2003). Recent
studies indicate that HB-EGF is expressed in the endocar-
dial epithelia, and participates in the formation of heart
valves (Iwamoto et al., 2003; Jackson et al., 2003). Al-
though the phenotypes of HB-EGF/ mice are not exactly
the same as those of Meltrin h/ mice, HB-EGF that is
expressed in the endocardial epithelia may be one of the
substrates of Meltrin h. Because Meltrin h is down-regu-
lated in the endocardial cushion of mice after E13.5 at
which point HB-EGF and TACE appear to be still highly
expressed, Meltrin h and TACE may act cooperatively
during cushion development. For example, Meltrin h may
regulate the generation of ErbB ligands during production
and proliferation of sparse cushion mesenchymes; TACE
then may then act on these substrates for further morpho-
genesis of cushion tissue containing dense mesenchymes.
Meltrin h protein is weakly activated during EMT, strongly
expressed in sparse mesenchymes in endocardial cushion at
E11.5 (Figs. 6E–G), and suppressed in dense mesenchymes
at E13.5. Expression of Meltrin h was higher in embryonic
fibroblasts cultured at low cell density than in those
cultured at high cell density (Komatsu K., an unpublished
result). Thus, cell density or cell–cell interactions may be
one of mechanisms that regulate expression of Meltrin h
proteases and their activities.
We predict that proteases different from Meltrin h and
TACE play regulatory roles in the ectodomain shedding of
Neuregulin. Although Neuregulin expressed in endocardial
cells is required for the embryonic cardiac myogenesis,
especially for ventricular trabeculation (Meyer and Birch-
meier, 1995), the proper cardiac muscle formation of Mel-
trin h/ and TACE/ mice during embryogenesis
indicates that the activation of Neuregulin for embryonic
development of cardiac muscle does not involve these
genes. Alternatively, soluble isoforms or membrane-an-
chored forms of Neuregulin themselves may play roles in
the early phase of cardiac muscle development.
Although we focused possible roles of Meltrin h protease
in the endocardial cushion development, the disintegrin and
another cystein-rich domains may also contribute to the
K. Kurohara et al. / Developmental Biology 267 (2004) 14–28 27remodeling of extracellular matrix proteins such as Fibro-
nectin. Disintegrins of various snake venoms can regulate
blood coagulation by disrupting interactions between Fi-
brinogen and Integrins (reviewed by Niewiarowski et al.,
1994) in blood platelets.
In conclusion, our analyses of Meltrin h/ mice showed
that Meltrin h plays key roles in the development of the
endocardial cushion. Meltrin h/ mice showed incorrect
positioning of the aorta, and hypertrophy of the right
ventricle in addition to VSD and defective formation of
the pulmonary valve, which are reminiscent of the defects of
Tetralogy of Fallot. It is plausible that Meltrin h is one of the
numerous genes responsible for this congenital heart disease
(Harvey, 2002; Kirby, 2002). Genetic studies of mice have
revealed that heart development requires complicated regu-
lations of intercellular signaling through ErbB receptors,
their ligands, and molecules that regulate ErbB signaling.
Considered together with previous results, our study sug-
gests that Meltrin h (ADAM19) is one such modifier
protease that modulates the ectodomain shedding of ErbB
ligands, including Neuregulin.Acknowledgments
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